ReviewAnnual review of pharmacology and toxicology2019

Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Leigh Goedeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.